WASHINGTON — Consumer Healthcare Products Association (CHPA) president & CEO Scott Melville released a statement today following President Donald Trump’s nomination of Dr. Heidi Overton to serve as the next Commissioner of the U.S. Food and Drug Administration (FDA).
“The Consumer Healthcare Products Association (CHPA) welcomes the nomination of Dr. Heidi Overton to serve as Commissioner of the U.S. Food and Drug Administration.
Dr. Overton has extensive experience in medicine, public health, and health policy, and we are encouraged by expressed interest in expanding Rx-to-OTC switch opportunities, increasing consumer access to self-care options, and exploring ways to bring innovative healthcare products to market more efficiently. Her public support for policies that promote competition, affordability, transparency, and informed consumer decision-making reflects the important role self-care can play in helping Americans take greater control of their health.
We look forward to learning more about Dr. Overton’s priorities as she moves through the confirmation process, and we are pleased the Administration is moving quickly to appoint a permanent leader of the FDA. Stable, science-based leadership is essential to a smooth-functioning FDA.”
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
